Ophthalmologists Conferences | Ophthalmology Conferences | International Ophthalmology Conferences | Ophthalmologists Congress | Amsterdam

Theme: Digitalization and Artificial Intelligence in the Field of Ophthalmology

Ophthalmologists 2022

Ophthalmologist 2022_SP

Ophthalmologists 2022

Dear Potential Researchers, Scientists, Industrialists & Students,

Join us for Ophthalmologists 2022

Update your skills, Meet your academic heroes, Engage in high-level debates and refine your ideas enhance your knowledge base, and broaden your horizons, Visit a new place and have fun, - all in one place!

March 21-22, 2022 | Amsterdam, Netherlands

The 22^nd Global Ophthalmologists Annual Meeting 2022, aims to provide a large platform to Surgeons, Opticians, Young Researchers and Students to share their knowledge and ideas on the Digital Revolution, advancement in the field of ophthalmology and the treatment to various eye disease and the risk as well as ease in surgery such as cataract, refractive surgeries etc.

Ophthalmology deals with the diagnosis and treatment of various eye disorders. Ophthalmic surgery also known as ocular surgery is a surgery performed on eyes by Ophthalmogist. An eye is a fragile organ which needs extreme care before and after surgery.

The simultaneous maturation of multiple digital and telecommunications technologies in 2021 has created an unprecedented opportunity for ophthalmology to adapt to new models of care using tele-health supported by digital innovations.

Ophthalmologists 2022 brings together a unique and international mix of large and medium pharmaceutical, biotech and diagnostic companies, leading universities and clinical research institutions making the conference a perfect platform to share experience, foster collaborations across industry and academia, and evaluate emerging technologies across the globe. Ophthalmology Congress 2022 maximizes the opportunity to interact with and learn from your peers from across the country and across the globe it held with the discussions on Cornea and External Eye Disease, Retina and Retinal Disorders, Neuro-Ophthalmology, Glaucoma: Visual Field Loss, Ocular Microbiology and Immunology, Novel Approaches to Ophthalmology therapeutics and many more.

Conference Series LLC LTD organizes 300+ meetings, 500+ workshops and 200+ symposiums on Clinical, Medicine, Pharma and Science and Technology consistently crosswise over USA, Europe, Asia, Middle East, Australia and UK with support from 1000 more logical social orders and Publishes 700 open get to diaries which contains more than 30000 famous identities, rumoured researchers as publication board individuals. Retinal issue, optic decay, and injuries of the higher visual pathways are the primary anatomical reasons for visual misfortune in youngsters.

Meet significant Ophthalmologists, Optometrists Researchers Clinicians from Singapore, Japan, Taiwan, China, Finland, Germany, Switzerland, Romania, Russia, UAE, Turkey, Spain, South Africa, Taiwan, Chicago, Malaysia, India, Indonesia, Australia and many more countries.

Ophthalmologists 2022 welcome the Scientists, Doctors, Academician, Researchers, Students, Business Entrepreneurs, etc. related to the broad areas of ophthalmology, Medical and Health care, Ophthalmology organizations are most likely to attend Ophthalmologists 2022 welcome the Scientists, Doctors, Academician, Researchers, Students, Business and utilize the scope of extending their skills, and their work on basic and significant applications. The theme of the conference is “Digitalization and Artificial Intelligence in the Field of Ophthalmology”. This Ophthalmology conference will be useful to participants from both the Industry and Academia working in all the domains of Health care sectors, all other target audience includes:

Researchers
Scientists
Health care experts
Ophthalmologists
Nutritionists/Dieticians
Diabetes Health Professionals
Physicians
Nurse practitioners
Health care analysts
Doctors
Academic researchers
Professors
Students
Research Institutes
Business delegates
Young Researchers
Advertising and Promotion Agency Executives
Professionals in media sector
Medical colleges
Ophthalmology Societies & Associations
Medical & Pharmaceutical Companies
Medical devices & companies
Others

1- Artificial Intelligence

The Artificial Intelligence in Ophthalmology mainly concentrates on the diseases with high occurrence such as glaucoma, cataract, retinopathy of prematurity, age related macular degeneration , diabetic retinopathy. In general AI refers to the task mainly completed by computers i.e., it involves minimum human.

Machine learning
Deep learning

2- Diabetic Retinopathy Screening

Diabetic retinopathy is a leading cause of blindness in the working age people. It leads to be a global health issue. Therefore it need to be detect potentially threatening changes at the early stage for timely treatment and management. The automatic identification of diabetic retinopathy has driven a lot of attraction with studies conducting exudation, haemorrhage, neovascularization detection etc. even at classify stage.

Fundus photography
Macular thickness mapping

3- Tele-ophthalmology

Tele-ophthalmology delivers the eye care through telecommunication technology and digital medical equipments. It offers eye specialist for patients in remote areas, ophthalmic disease screening, diagnosis and monitoring. At present the tele-ophthalmology focus on disease such as diabetic retinopathy, macular degeneration, adnexal eye diseases, retinopathy of prematurity strabismus.

Automatic image recognition
Synchronous tele-ophthalmology
Asynchronous tele-ophthalmology

4- Retinitis Pigmentosa (RP)

Retinitis pigmentosa is a genetic disorder that involve breakdown and loss of retinal cells i.e., back wall of eye is damaged. It include decreased vision at night or loss of tunnel vision. There is no permanent treatment till date developed for Retinitis Pigmentosa but some measures can be taken such as mobility training, portable lightning and low vision aid.

5- Telemedicine

Telemedicine enable clinicians to evaluate their patients remotely. This is helpful for many reasons. It provide more efficient distribution of limited healthcare facilities and also save waiting time. It proves to be very helpful at the time of pandemic when their was shortage of Doctors.

Bio microscopic videography
Real time Telemedication

6- Glaucoma

Artificial Intelligence has the capability to modernize the screening, diagnosis, and classification of glaucoma by both through the automated processing of large data sets, and by earlier detection of new disease pattern. AI also promise for the fundamentally changing research aimed at understanding the development, progression and treatment of Glaucoma by identifying novel risk factors.

Optical coherence tomography
Fundus photography

7-Myopia (Nearsightedness)

Myopia (nearsightedness) is a common vision condition in which you can see objects near to you clearly, but objects farther away are blurry. It occurs when the shape of your eye causes light rays to bend (refract) incorrectly, focusing images in front of your retina instead of on your retina.

Is Myopia genetic?
Is Myopia caused by phones?

8- Refractive error correction

Ocular wavelength error is most commonly described polynomial. This work aimed to use artificial intelligence to predict subjective refraction from wavefront aberrometry data processed with a novel polynomial decomposition basis. AI can facilitate quantification of disease severity, surgical planning and longitudinal monitoring of treatment response.

Artificial Neural Network
Case based Fuzzy logic
Decision tree

9- Cataract

Artificial Intelligence has proven promising in cataract surgery. AI can demonstrate different phases of cataract. With the increase and improvement in the availability of ocular imaging modalities, including retinal camera, hand-held camera the AI system can provide better outreach for cataract screening.

Age related
Congenital

10- Retinopathy of Prematurity

Retinopathy of prematurity or ROP is a cause of childhood blindness all over the world and treatable with early and timely diagnosis. ROP screening consumes more time and power but digitalization and introduction of artificial intelligence in ROP can save the efforts and time and increase efficiency. Automatic identification ROP has achieved a promising result.

Blindness
ROP Screening

Age-related macular degeneration (AMD) is a serious irreversible macular disease characterized by retinal pigment changes, choroidal neovascularization, haemorrhage and even geographical atrophy. It is one of the leading causes of central vision loss in people aged over 50. Screening of AMD is required to be done daily. Automatic AMD increase efficiency and reduce workload of clinicians.

Vision Loss over 50
AMD Screening

12- Retinal Vein Occlusion

After Diabetic Retinopathy, Retinal vein occlusion is the cause of vision loss. The main reason of RVO or retinal vein occlusion is the sclerotic retinal artery compress the retinal vein and block the blood return of terminal arborizations. It causes haemorrhage, exudation and retinal edema. It may lead to decrease in vision and even blindness. Its risk factors are mainly the old aged people and thus the early diagnosis of RVO is crucial for vision recovery. The machine learning in RVO is relatively less but it would be a ease of both patients and ophthalmologist.

Sclerotic Retinal Artery Compress
Retinal Edema

13- Challenges in Implementation of Artificial Intelligence

Artificial Intelligence has proved to be an ease in the field of Ophthalmology but it has some challenges to as computation is not advanced, Wide spread to AI has generated various ethical and legal issues. Very few people supports and implement Artificial Intelligence in their lives.

· Technical Challenges

· Socioculture Challenges

· Physical Challenges

Recommended: Ophthalmology Conferences | International Ophthalmology Conferences | Ophthalmology Meetings | Ophthalmologists Conferences

14- Ocular Tumors

Ocular tumor are the tumors inside the eyes. They can be benign or malignant. They are a collection of cell growth. The eye tumor first appear as a dark spot on the iris and causes blurry vision. Some eye tumor occurs on conjunctiva. Early detection of eye cancer allows more treatment options.

·Choroidal melanoma

·Melignant melanoma

·Ocular melanoma

15- Strabismus and Artificial intelligence

Clinical evaluation of ocular vision plays an important role in the diagnosis of special strabisumus. Despite of their importance, they are not standardized in clinical practice because they are subjective. Therefore, artificial intelligence is introduced which classify the eye versions into nine positions of gaze.

Fundoscopy
Hypofunction
Hyperfuction
Convolution Neural Network

16- Ocular Gene Therapy

Ocular gene therapy has made a rapid progress in the past few years. This method directly administered into the eye, targeting diseases caused by mutations in the gene RPE65. Mutations in ths gene can produce Retinitis Pigmentosa, a rare but potentially Blinding diseases.

Gene replacement
DNA Nanoparticle
RNA Interference
Ex vivo for Retinal Pigmentosa

17- Gene therapy of Retinal Diseases

Gene therapy is growing potentially in the field of ophthalmology having mailnly three characteristics- convenience in terms of injections and eye surgery, tight blood-ocular barriers which save other organ from contamination, its immune-privileged status facilitating the accommodation to the antigenicity of a viral vector.

Adeno-associated Viral Gene Therapy
Laser Congenital Amaurosis
Usher’s Syndrome

18- Achromatopsia

Achromatopsia, also known as color blindness, the inability to perceive color and to achieve satisfactory visual acuity at high levels, mainly in exterior daylight. It is estimated to affect 1 in 30,000 live births worldwide. It shows symptoms like- Amblyopia, hemeralopia, nystagmus and iris operationg abnormalities.

Complete Achromatopsia
Incomplete Achromatopsia
Congenital Achromatopsia

19- Leber Hereditary Optic Neuropathy (LHON)

Leber hereditay optic neuropathy or LHON is a common inhereditary mitochondrial disorder mainly occulr in young males and also known as sudden vision loss as cells in retina starts to die. It starts with a painless cloudiness in vision and then worsen with the loss of sharpness and vision loss.

Etiology
Pathophysiology

20- Retinoschisis

Retinoschisis is a splitting of eye retina into two layers. This disorder is characterized with the slow loss of parts of vision corresponding to the areas of the retina that have become split. It may also be associated with the development of Saclike blisters called retinal cysts.

Senile Retinoschisis
Juvinile Rectinoschisis

21- Artificial Intelligence for Optical Coherence Tomography in Choroideremia

Choroidermia is genetic disorder of sight which generally effects the males. Optical coherence tomography (OCT) can describes the early deterioration of the photoreceptor integrity caused by inherited retinal degeberation diseases (IRDs). Artificial Intelligence method of machine learning based on random forests was developed to automatically detect continuous areas of preserved ellipsoid zone structure.

Gyrate Atrophy
X-linked Retinitis Pigmentosa

Ophthalmic devices market by product function (Surgical devices- Refractive error surgery devices, Glaucoma surgery devices, Cataract surgery devices and Vitreoretinal surgery devices; Ophthalmic diagnostic devices- Refractors, Corneal topography systems, Retinal ultrasound systems, Fundus camera, Ophthalmoscopes, OCT, Perimeters, Slit lamps and Tonometer; and Vision care devices- Contact lenses and spectacles) size was valued at $53,428.8 million in 2019, and is projected tp reach $66,719.3 million by 2027, registering a CAGR of 4.2% from 2020 to 2027.

The emergence of the novel coronavirus SARS-CoV-2, and the resulting disease Covid-19, has created a major international public health challenge. As the government has imposed lockdown, the ophthalmology diagnostics clinics are closed and the surgeries are postponed which is expected to limit the growth of the market.

Region wise, the ophthalmic devices market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. The North America ophthalmic devices market accounted for the largest share in 2019; however, Asia-Pacific is anticipated to register the highest CAGR of 4.6% throughout the forecast period. According to the Center for Diseases Control and Prevention, diabetic retinopathy is expected to account for major cause of blindness in the U.S. From 2010 to 2050, the number of Americans with diabetic retinopathy is expected to nearly double from 7.7 million to 14.6 million. Glaucoma further contributes toward the loss of vision and blindness.

Covid-19 Impact on the Ophthalmic Equipment Market

The ophthalmic equipment market is predicted to be negatively impacted by the COVID-19 pandemic in 2020-2021. Due to the COVID-19 outbreak, there has been a big drop by patient visits to clinics thanks to lockdowns and constraints implemented to stop the spread of the disease. This has led to a decline within the number of elective eye surgeries being conducted per week in hospitals and clinics. According to the Ophthalmology Times article, the amount of elective surgeries has reduced from 200 surgeries to only ten surgeries every week. Also, countries like Boston have witnessed 15% cancellations in patient visits to examination centers.

Governments have also issued restriction and prohibition on medical procedures and elective surgeries. These restrictions have set back the demand for ophthalmic equipment. Due to these limitations, manufacturing companies of ophthalmic equipment face problems in conducting in-person product demonstrations, operating their facilities at full capacity, and attending or organizing conferences. Lockdowns in APAC countries like China and India have delayed the assembly and shipment of ophthalmic devices. All these factors act as a challenge for the expansion of the ophthalmic equipment market. Ophthalmic Equipment Market Dynamics.

With all the Expert scientific people over the world focused on learning about Digitalization and artificial intelligence in the field of ophthalmology and advanced strategies and technologies emerging in Ophthalmological research areas. This is the largest globalized platform for the assemblage of world’s best speakers, researchers and participants from the field of Ophthalmology. Attending a conference means that you can meet more and more advanced researchers, as well as established senior professionals and scholars. Listening to talks and presentations can open up new ways of thinking about a specific topic or even give you a new idea, one that you had previously not though about.

Target Audience:

Clinical researchers & Scientists
Public Health Professional
Ophthalmic surgeons
Retina and Retinal Surgery
Glaucoma
Optometrists
Medical Practitioners, Professors, Deans, Students & Technicians
Medical & Health care Organizations & Associations
Researchers & Scholars

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	March 21-22, 2022
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed
Poster Opportunity Closed	Click Here to View

22^nd Global Ophthalmologists Annual meeting March 21-22, 2022 Amsterdam, Netherlands

Recommended Global Ophthalmology Conferences

USA & Americas

Europe & Middle East

Asia Pacific

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com

Quick Links

Ophthalmologists 2022

Ophthalmologists 2022

Ophthalmologists 2022

Ophthalmologists 2022

13- Challenges in Implementation of Artificial Intelligence

· Technical Challenges

· Socioculture Challenges

· Physical Challenges

Recommended: Ophthalmology Conferences | International Ophthalmology Conferences | Ophthalmology Meetings | Ophthalmologists Conferences

14- Ocular Tumors

Ocular tumor are the tumors inside the eyes. They can be benign or malignant. They are a collection of cell growth. The eye tumor first appear as a dark spot on the iris and causes blurry vision. Some eye tumor occurs on conjunctiva. Early detection of eye cancer allows more treatment options.

·Choroidal melanoma

·Melignant melanoma

·Ocular melanoma

Conference Highlights

To Collaborate Scientific Professionals around the World

Useful Links

Special Issues